Source: KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs, May 2024 In a Morgan Stanley Research survey, weight-loss drugs users reported eating less food in general, with half of respondents cutting their consumption of sugary drinks, alcohol, confections and salty snacks
Yusta B, Baggio LL, Koehler J et al (2015) GLP-1R agonists modulate enteric Immune responses through the intestinal intraepithelial lymphocyte GLP-1R
The approval of semaglutide signifies its utility in addressing the complications associated with diabetes and obesity, such as: Heart disease Stroke Kidney problems Nerve damage Eye problems This medication plays a crucial role in enhancing overall health and decreasing the risk of heart attacks, strokes, and other diabetes-related complications
For a deeper look at the delivery method, our All About Liposomes guide explains the basics